Moolec Science SA (MLEC) Tops Q4 EPS by 1c

Moolec Science SA (NASDAQ: MLEC) reported Q4 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $250 thousand versus the consensus estimate of $615 thousand.

For earnings history and earnings-related data on Moolec Science SA (MLEC) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c